127 related articles for article (PubMed ID: 38868364)
1. Effective intravitreal gene delivery to retinal pigment epithelium with hyaluronic acid nanospheres.
Crane R; Makia MS; Zeibak S; Tebbe L; Ikele L; Woods CR; Conley SM; Acharya G; Naash MI; Al-Ubaidi MR
Mol Ther Nucleic Acids; 2024 Jun; 35(2):102222. PubMed ID: 38868364
[TBL] [Abstract][Full Text] [Related]
2. Co-Injection of Sulfotyrosine Facilitates Retinal Uptake of Hyaluronic Acid Nanospheres Following Intravitreal Injection.
Eblimit A; Makia MS; Strayve D; Crane R; Conley SM; Sinha T; Acharya G; Al-Ubaidi MR; Naash MI
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575586
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.
Li W; Kong F; Li X; Dai X; Liu X; Zheng Q; Wu R; Zhou X; Lü F; Chang B; Li Q; Hauswirth WW; Qu J; Pang JJ
Mol Vis; 2009; 15():267-75. PubMed ID: 19190735
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan-modified core-shell liponanoparticles targeting CD44-positive retinal pigment epithelium cells via intravitreal injection.
Gan L; Wang J; Zhao Y; Chen D; Zhu C; Liu J; Gan Y
Biomaterials; 2013 Aug; 34(24):5978-87. PubMed ID: 23680367
[TBL] [Abstract][Full Text] [Related]
5. The future of retinal gene therapy: evolving from subretinal to intravitreal vector delivery.
Ross M; Ofri R
Neural Regen Res; 2021 Sep; 16(9):1751-1759. PubMed ID: 33510064
[TBL] [Abstract][Full Text] [Related]
6. G-quartet oligonucleotide mediated delivery of functional X-linked inhibitor of apoptosis protein into retinal cells following intravitreal injection.
Talreja D; Cashman SM; Dasari B; Kumar B; Kumar-Singh R
Exp Eye Res; 2018 Oct; 175():20-31. PubMed ID: 29864441
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for inherited retinal diseases: progress and possibilities.
Hu ML; Edwards TL; O'Hare F; Hickey DG; Wang JH; Liu Z; Ayton LN
Clin Exp Optom; 2021 May; 104(4):444-454. PubMed ID: 33689657
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal Injection of Normal Saline Induces Retinal Degeneration in the C57BL/6J Mouse.
Hombrebueno JR; Luo C; Guo L; Chen M; Xu H
Transl Vis Sci Technol; 2014 Mar; 3(2):3. PubMed ID: 24757593
[TBL] [Abstract][Full Text] [Related]
9. Apical CLC-2 in retinal pigment epithelium is crucial for survival of the outer retina.
Hanke-Gogokhia C; Lehmann GL; Benedicto I; de la Fuente-Ortega E; Arshavsky VY; Schreiner R; Rodriguez-Boulan E
FASEB J; 2021 Jul; 35(7):e21689. PubMed ID: 34085737
[TBL] [Abstract][Full Text] [Related]
10. The obstacle course to the inner retina: Hyaluronic acid-coated lipoplexes cross the vitreous but fail to overcome the inner limiting membrane.
Devoldere J; Wels M; Peynshaert K; Dewitte H; De Smedt SC; Remaut K
Eur J Pharm Biopharm; 2019 Aug; 141():161-171. PubMed ID: 31150809
[TBL] [Abstract][Full Text] [Related]
11. Changes in adeno-associated virus-mediated gene delivery in retinal degeneration.
Kolstad KD; Dalkara D; Guerin K; Visel M; Hoffmann N; Schaffer DV; Flannery JG
Hum Gene Ther; 2010 May; 21(5):571-8. PubMed ID: 20021232
[TBL] [Abstract][Full Text] [Related]
12. Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy.
Martens TF; Remaut K; Deschout H; Engbersen JF; Hennink WE; van Steenbergen MJ; Demeester J; De Smedt SC; Braeckmans K
J Control Release; 2015 Mar; 202():83-92. PubMed ID: 25634806
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid-modified cationic niosomes for ocular gene delivery: improving transfection efficiency in retinal pigment epithelium.
Qin Y; Tian Y; Liu Y; Li D; Zhang H; Yang Y; Qi J; Wang H; Gan L
J Pharm Pharmacol; 2018 Sep; 70(9):1139-1151. PubMed ID: 29931682
[TBL] [Abstract][Full Text] [Related]
14. Cell-cell interaction in the pathogenesis of inherited retinal diseases.
Du X; Butler AG; Chen HY
Front Cell Dev Biol; 2024; 12():1332944. PubMed ID: 38500685
[TBL] [Abstract][Full Text] [Related]
15. Comparison of wild-type and class I integrase mutant-FIV vectors in retina demonstrates sustained expression of integrated transgenes in retinal pigment epithelium.
Loewen N; Leske DA; Chen Y; Teo WL; Saenz DT; Peretz M; Holmes JM; Poeschla EM
J Gene Med; 2003 Dec; 5(12):1009-17. PubMed ID: 14661176
[TBL] [Abstract][Full Text] [Related]
16. Tuning surface functionalities of sub-10 nm-sized nanocarriers to target outer retina in designing drug delivery agents for intravitreal administration.
You S; Kim H; Jung HY; Kim B; Lee EJ; Kim JW; Kim Y
Biomaterials; 2020 Oct; 255():120188. PubMed ID: 32652402
[TBL] [Abstract][Full Text] [Related]
17. DNA nanoparticles are safe and nontoxic in non-human primate eyes.
Kelley RA; Conley SM; Makkia R; Watson JN; Han Z; Cooper MJ; Naash MI
Int J Nanomedicine; 2018; 13():1361-1379. PubMed ID: 29563793
[TBL] [Abstract][Full Text] [Related]
18. SubILM Injection of AAV for Gene Delivery to the Retina.
Gamlin PD; Alexander JJ; Boye SL; Witherspoon CD; Boye SE
Methods Mol Biol; 2019; 1950():249-262. PubMed ID: 30783978
[TBL] [Abstract][Full Text] [Related]
19. G-quartet oligonucleotide mediated delivery of proteins into photoreceptors and retinal pigment epithelium via intravitreal injection.
Leaderer D; Cashman SM; Kumar-Singh R
Exp Eye Res; 2016 Apr; 145():380-392. PubMed ID: 26923800
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Gene Delivery in Retinal Pigment Epithelium Cells by Plasmid DNA-Wrapped Gold Nanoparticles.
Trigueros S; Domènech EB; Toulis V; Marfany G
Genes (Basel); 2019 Apr; 10(4):. PubMed ID: 30970664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
